Global Cervical Cancer Diagnostics Market to Reach $12.5 Billion by 2029, Growing at 6.1% CAGR

What Is the Expected Size and Growth Rate of the Cervical Cancer Diagnostics Market?
The market size for cervical cancer diagnostics has been experiencing robust growth lately. The market is predicted to expand from $9.27 billion in 2024 to $9.85 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.2%. The considerable growth observed in the historical period can be ascribed to rising awareness and screening programs, hpv vaccination, technological progressions, and an aging demographic.

The market size for cervical cancer diagnostics is projected to experience robust growth in the coming years, with an estimated value of $12.5 billion by 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth trend for the forecasted period can be associated with the rise in hpv-related cancers, advancements in molecular testing, the emergence of new markets, and the implementation of telemedicine and remote screening. Significant trends for the projection period encompass hpv testing, liquid-based cytology, automation, digital pathology, and screen-and-treat programs.

What Factors Are Fueling Growth in the Cervical Cancer Diagnostics Market?
The escalating uptake of diagnostic tests for cervical cancer in early detection stages is predicted to fuel the cervical cancer diagnostics market. The worldwide elevation in awareness about cervical cancer in women, coupled with the stress on early screening for the detection and prevention of the disease by both global cancer organizations and governments, augments market growth. For example, the US reported 12,536 fresh incidences of cervical cancer back in July 2024, as per the Centers for Disease Control and Prevention, a US-based government entity, data from 2021. In 2022, the illness posed 4,051 fatalities in women. This mounting adoption of diagnostic procedures for cervical cancer and the focus on early detection are driving forces for the expansion of the cervical cancer diagnostics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3285&type=smp

Which Leading Companies Are Shaping the Growth of the Cervical Cancer Diagnostics Market?
Major companies operating in the cervical cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Zilico Ltd., Guided Therapeutics Inc., Thermo Fisher Scientific Inc., Carl Zeiss AG, OncoHealth Corporation, Arbor Vita Corporation, Micromedic Technologies Ltd., Trovagene Inc., Roche Diagnostics, Nucleix Ltd., BGI Genomics Co. Ltd., Cepheid, Exact Sciences Corporation, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., PerkinElmer Inc., Sysmex Corporation, Veracyte Inc., Zymo Research Corporation

What Are the Major Trends Shaping the Cervical Cancer Diagnostics Market?
Key entities in the cervical cancer diagnostics market, such as leading corporations, are focusing their efforts on the creation of novel technological solutions like HPV self-collection solutions for cervical cancer. This solution takes diagnosing cervical cancer a notch higher by enhancing screening accessibility and improving early detection rates. The technique empowers individuals to self-collect samples for HPV testing, a significant cause of cervical cancer. In a notable development, the Switzerland-based pharmaceutical firm F. Hoffmann-La Roche AG obtained FDA approval for its HPV self-collection solution in May 2024. This significant leap in cervical cancer screening amplifies access for all, particularly marginalized communities. The pioneering procedure allows women to discreetly collect vaginal samples for scrutiny using Roche's Cobas molecular HPV test. This aligns with the World Health Organization's objective to wipe out cervical cancer by 2030. The sanction comes on the heels of the successful IMPACT trial, evidencing the solution's effectiveness across a range of demographics.

What Are the Key Segments of the Cervical Cancer Diagnostics Market?
The cervical cancer diagnostics market covered in this report is segmented -

1) By Diagnostic Test: Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests
2) By Age Group: Below 21, Age between 21 to 29, Age between 30 to 65, Above 65
3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Diagnostic Centers

Subsegments:
1) By Pap Smear Test: Conventional Pap Smear, Liquid-Based Pap Smear
2) By HPV Test: DNA-Based HPV Test, RNA-Based HPV Test, Hybrid Capture HPV Test, Other HPV Tests
3) By Colposcopy: Standard Colposcopy, Digital Colposcopy, Optical Colposcopy
4) By Biopsy And Endocervical Curettage: Punch Biopsy, Endocervical Curettage (ECC), Cone Biopsy, Colposcopic Biopsy
5) By Other Diagnostic Tests: Visual Inspection With Acetic Acid (VIA), Cervical Cytology Testing, Blood Tests, Other Specialty Tests

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report

Which Region Dominates the Cervical Cancer Diagnostics Market?
North America was the largest region in the cervical cancer diagnostics market in 2023 Asia-Pacific was the second largest region in the cervical cancer diagnostics market. The regions covered in the cervical cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Cervical Cancer Diagnostics Global Market Report?

- Market Size Analysis: Analyze the Cervical Cancer Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Cervical Cancer Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Cervical Cancer Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Cervical Cancer Diagnostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3285

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.